INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2014
|
Net Assets |
£187m |
|
Net Assets per share |
339p |
|
Share price |
278p |
|
Total value of unquoted investments |
£18m |
|
Total number of portfolio companies |
90 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Gilead |
8.6 |
|
Alexion |
8.2 |
|
Biogen |
7.4 |
|
Celgene |
7.0 |
|
Amgen |
5.7 |
|
Illumina |
3.9 |
|
Mylan |
3.2 |
|
Vertex |
3.1 |
|
Regeneron |
2.7 |
|
Shire |
2.6 |
|
|
----------- |
|
Total |
52.4 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
64 |
|
Turning Profitable 2015 |
9 |
|
Unprofitable |
27 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
89 |
|
Europe & UK |
11 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
91 |
|
Unquoted |
9 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JUNE 2014